References
- Brock DJH, Sutcliffe RG. Alpha-fetoprotein in the antenatal diagnosis of anencephaly and spina bifida. Lancet 1972; 2: 197–9
- United Kingdom Collaborative Study on Alpha-fetoprotein in Relation to Neural Tube Defect. Amniotic fluid alpha-fetoprotein measurement in antenatal diagnosis of anencephaly and open spina bifida in early pregnancy. Lancet 1979; i: 651–62.
- Goldberg MF, Oakley GP. Interpreting elevated amniotic fluid alpha-fetoprotein levels in clinical practice: use of predictive value positive concept. Am J Obstet Gynecol 1979; 133: 126–32
- Kimball ME, Milunsky A, Alpert E. Prenatal diagnosis of neural tube defects. III. A re-evaluation of the alpha-fetoprotein assay. Obstet Gynecol 1977; 49: 532–6
- Fisher NL, Luthy DA, Peterson A, Karp LE, Williamson R, Cheng E. Prenatal diagnosis of neural tube defects: predictive value of AF-AFP in a low-risk population. Am J Med Genet 1981; 9: 201–9
- Shields LE, Uhrich SB, Komarniski CA, Wener MH, Winter TC. Amniotic fluid alpha-fetoprotein determination at the time of genetic amniocentesis: has it outlived its usefulness?. J Ultrasound Med 1996; 15: 735–9
- Mandruzzato GP, Fischer-Tamaro L, De Seta F, D'Ottavio G, Rustico MA, Conoscenti G. Does amniotic fluid alpha-fetoprotein have diagnostic or prognostic value at the time of second midtrimester genetic amniocentesis?. Fetal Diagn Ther 2002; 17: 147–52
- Silver RK, Leeth EA, Check IJ. A reappraisal of amniotic fluid α-fetoprotein measurement at the time of genetic amniocentesis and midtrimester ultrasonography. J Ultrasound Med 2001; 20: 631–7
- Routine ultrasound examination during pregnancy. The Swedish Council on Technology Assessment in Health Care, SBU-rapport nr 139.
- Nicolaides KH, Campell S, Gabbe SG, Guidetti R. Ultrasound screening for spina bifida: cranial and cerebellar signs. Lancet ; 2 1986; 12: 72–4
- Van den Hof MC, Nicolaides KH, Campell J, Campell S. Evaluation of lemon and banana signs in one hundred thirty fetuses with open spina bifida. Am J Obstet Gynecol 1990; 162: 322–7
- Coombes E, Moody B, Howard J. Comparison of a time-resolved fluoroimmunoassay with a solid phase immunoradiometric assay for the measurement of alphafetoprotein in amniotic fluid. J Automatic Chem 1987; 9: 129–31
- Tabor A, Philip J, Madsen M, Bang J, Obel EB, Nörgaard-Pedersen B. Randomized controlled trial of genetic amniocentesis in 4606 low-risk women. Lancet 1986; i: 1287–93
- Schnittger A, Kjessler B. The outcome of a uniform program for alpha-fetoprotein screening in early pregnancy in seven regions in Sweden. Acta Obstet Gynecol Scand Suppl 1984; 119: 9–23
- Crandall BF. Alpha-fetoprotein: a review. Crit Rev Clin Lab Sci 1981; 15: 127–84
- Pandya PP, Snijders RJ, Johnson SP, De Lourdes Brizot M, Nicolaides KH. Screening for fetal trisomies by maternal age and fetal nuchal translucency thickness at 10 to 14 weeks of gestation. Br J Obstet Gynaecol 1995; 102: 957–62
- Hogge WA, Thiagarajah S, Ferguson JE, Schnatterly PT, Harbert GM. The role of ultrasonography and amniocentesis in the evaluation of pregnancies at risk of neural tube defects. Am J Obstet Gynecol 1989; 161: 520–4